TFF Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 46.5%.

Top 25 shareholders own 26.1% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
8.47%	Carlson Capital, L.P.	293,460	US$109.3k	0%	-0.23%
6.58%	Armistice Capital LLC	228,000	US$84.9k	22.8%	no data
3.92%	Intracoastal Capital LLC	135,700	US$50.5k	0%	no data
1.46%	Westside Investment Management, LLC	50,491	US$18.8k	0%	no data
1.15%	DRW Trading Group, Asset Management Arm	40,000	US$14.9k	0%	no data
0.94%	Harlan Weisman	32,585	US$12.1k	0%	no data
0.81%	Geode Capital Management, LLC	27,999	US$10.4k	28.5%	no data
0.59%	Renaissance Technologies LLC	20,497	US$7.6k	38.7%	no data
0.39%	Citadel Advisors LLC	13,579	US$5.1k	0%	no data
0.35%	The Vanguard Group, Inc.	12,136	US$4.5k	0%	no data
0.34%	Laurence Lytton	11,900	US$4.4k	0%	no data
0.3%	NWAM, LLC	10,240	US$3.8k	0%	no data
0.21%	BlackRock, Inc.	7,186	US$2.7k	0%	no data
0.16%	Zamaneh Mikhak	5,400	US$2.0k	0%	no data
0.13%	Investicna a Dochodkova sprav. spol., a.s.	4,418	US$1.6k	0%	no data
0.065%	Robert Mills	2,239	US$833.6	0%	no data
0.056%	Tower Research Capital Europe Limited	1,948	US$725.2	-60.5%	no data
0.042%	Stephen Rocamboli	1,440	US$536.2	0%	no data
0.041%	Kirk Coleman	1,427	US$531.3	0%	no data
0.029%	Nordwand Advisors, LLC	1,000	US$372.3	0%	no data
0.025%	The University of Texas/Texas A&M Investment Management Company	882	US$328.4	0%	no data
0.023%	Brandi Roberts	800	US$297.8	0%	no data
0.019%	UBS Asset Management AG	675	US$251.2	-8.16%	no data
0.016%	ORG Partners LLC	540	US$201.0	-27%	no data
0.0045%	Royal Bank of Canada, Banking & Securities Investments	156	US$58.1	0%	no data